Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants with Hemiretinal Vein Occlusion Compared With Participants with Central Retinal Vein Occlusion (SCORE2) Report 18
Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion
Factors Associated with Favourable 5 Year Outcomes in Islet Transplant Alone Recipients with Type 1 Diabetes Complicated By Severe Hypoglycaemia In The Collaborative Islet Transplant Registry